Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-04 GREER R SCOTT Director Sale −1,400 $61.99 $87K 130,333
2018-06-04 GREER R SCOTT Director Exercise or conversion · Stock Option −1,400 28,600
2018-05-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −3,576 $83.39 $298K 65,281
2018-05-16 ROBIN HOWARD W President & CEO Sale −12,791 $83.39 $1.1M 224,356
2018-05-16 Nicholson John SVP & Chief Operating Officer Sale −4,917 $83.39 $410K 162,596
2018-05-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −4,941 $83.39 $412K 94,798
2018-05-16 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −4,060 $83.39 $339K 76,201
2018-05-16 Doberstein Stephen K SVP & Chief Scientific Officer Sale −3,435 $83.39 $286K 63,959
2018-05-03 CHESS ROBERT Director Exercise or conversion +10,000 $14.26 $143K 284,223
2018-05-03 CHESS ROBERT Director Sale −10,000 $82.79 $828K 274,223
2018-05-03 CHESS ROBERT Director Exercise or conversion +15,000 $5.14 $77K 289,223
2018-05-03 CHESS ROBERT Director Sale −15,000 $82.81 $1.2M 274,223
2018-05-03 CHESS ROBERT Director Exercise or conversion · Stock Option −10,000 10,000
2018-05-03 CHESS ROBERT Director Exercise or conversion · Stock Option −15,000 0
2018-05-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +30,000 $10.69 $321K 129,739
2018-05-03 Labrucherie Gil M SVP & Chief Financial Officer Sale −30,000 $82.86 $2.5M 99,739
2018-05-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −30,000 0
2018-05-03 ROBIN HOWARD W President & CEO Exercise or conversion +43,333 $10.69 $463K 280,480
2018-05-03 ROBIN HOWARD W President & CEO Sale −43,333 $82.86 $3.6M 237,147
2018-05-03 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −43,333 170,000

Page 32 of 43 · 847 trades